Sending Office: Honorable Anna G. Eshoo
Support a Congressionally Directed Peer Review Arthritis Research Program
Deadline: March 14, 2018
Please join us in writing to the Defense Appropriations Subcommittee to support a Peer Review Arthritis Research Program within the Congressionally Directed Medical Research Program (CDMRP). Arthritis affects 1 in 3 veterans, and is the second leading cause
of medical discharge from the U.S. Army.
The physical demands of military service increase the risks for service members to develop arthritis. This translates to younger people developing arthritis, with corresponding health care and disability compensation costs ultimately being borne by the U.S.
taxpayer. A dedicated arthritis research program would ensure a consistent, stable funding stream to building off of initial research and lead to breakthroughs, which will ultimately benefit all Americans with arthritis.
We encourage you to show your support for a Congressional Directed Peer Review Arthritis Research Program given the enormous burden arthritis places on service members and to the health care system. To support funding for the Peer Review Arthritis Research
program, please contact Rachel Fybel with Rep. Eshoo at
Rachel.Fybel@mail.house.gov or Christopher Buki with Rep. McKinley at
Christopher.Buki@mail.house.gov by COB March 14th.
Anna G. Eshoo David B. McKinley, P.E.
Member of Congress Member of Congress
The Honorable Kay Granger The Honorable Pete Visclosky
Chairman Ranking Member
Subcommittee on Defense Subcommittee on Defense
1026 Longworth House Office Building 2328 Rayburn House Office Building
Washington, DC 20515 Washington, DC 20515
Dear Chairman Granger and Ranking Member Visclosky,
As you prepare the Fiscal Year 2019 Department of Defense (DoD) Appropriations bill, we respectfully request that you include a Peer Review Arthritis Research Program within the Congressionally Directed Medical Research Program (CDMRP). Arthritis affects
1 in 3 veterans, compared to 1 in 4 civilians, and it is the second leading cause of medical discharge from the U.S. Army. Arthritis has a profound effect on our military readiness and retention. Dedicated funding for arthritis research at DoD is critical
to finding interventions and treatments to help our service members and veterans.
The physical demands of military service increase the risks for service members to develop arthritis. Combat injuries often lead to post-traumatic osteoarthritis, and service members often begin experiencing symptoms within 2 years of injury. This translates
to younger people developing arthritis, higher discharge rates, and many more life years of arthritis-related health care needs and costs. As service members return from overseas contingency operations, these statistics may get even worse. Data show that musculoskeletal
disorders were the leading cause of medical evacuation from Iraq and Afghanistan. The health care and disability compensation costs are staggering – over $975,000 a person – and are ultimately borne by the U.S. taxpayer. The return on investment from developing
better interventions and treatments, and ultimately preventing arthritis, are huge, both in terms of cost and quality of life among our military personnel.
The DoD Peer Reviewed Medical Research Program (PRMRP) has been funding arthritis research since FY2009 but given the many priorities of the PRMRP, arthritis funding is not guaranteed. Some of the early arthritis research is investigating why outcomes are
poorer for military personnel and possible ways to reduce the symptoms and potentially prevent the onset of arthritis following injury. Additional research is needed on better joint injury management and the development of treatments for osteoarthritis. A
dedicated arthritis research program would ensure a consistent, stable funding stream to build off of this initial research and lead to breakthroughs which will ultimately benefit all Americans with arthritis.
It is essential to conduct this research at DoD. Studying service members requires access to military health records and the ability to identify and enroll military personnel in clinical trials. The risks of arthritis among our military personnel are directly
related to military service and their treatment needs may be different.
We urge you to consider the enormous burden arthritis places on service members and the health care system, and include a dedicated arthritis research program within the CDMRP in FY2019.
e-Dear Colleague version 2.0